Diabetes Clinical Trials in Chicago

Showing 361-380 of 574 trials

A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

NCT00831129

The purpose of this research study is to examine if a combination of a cholesterol lowering-drug, simvastatin, with a sugar-lowering drug called rosiglitazone is more effective in improving vascular inflammation (irritation of the vessels that transport your blood) and other cardiovascular risk factors than the taking of simvastatin alone.

Pre-diabetes

University of Chicago53 participantsStarted Sep 2006

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

NCT00399711

This trial is conducted in the United States of America (USA). This trial compares the changes in HbA1c after 26 weeks of repaglinide and metformin fixed dose combination tablet given as twice daily versus three times daily regimens or versus twice daily rosiglitazone and metformin fixed dose combination tablet in subjects with type 2 diabetes currently on monotherapy.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S560 participantsStarted Nov 2006

Vestavia Hills, Alabama, United States • Glendale, Arizona, United States • Mesa, Arizona, United States +100 more locations

A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

Diabetes Trials in Other Cities

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

A Study of Aleglitazar in Patients With Type 2 Diabetes

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes

Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

Other Conditions in Chicago